Unbound Free Fatty Acid Profiles in Human Plasma and the Unexpected Absence of Unbound Palmitoleate
Overview
Authors
Affiliations
We determined for the first time the profiles of the nine most abundant unbound FFAs (FFAus) in human plasma. Profiles were determined for a standard reference plasma of pooled healthy adults for which the Lipid MAPSMAPS Consortium had determined the total FFA profiles. Measurements were performed by using 20 different acrylodan-labeled fatty acid binding protein mutants (probes), which have complementary specificities for the nine FFAs that comprise more than 96% of long-chain plasma FFA. The acrylodan fluorescence emission for each probe changes upon binding a FFAu. The plasma concentrations of each of the nine FFAus were determined by combining the measured fluorescence ratios of the 20 probes. The total molar FFAu concentration accounted for <10 of the total FFA concentration, and the mole fractions of the FFAu profiles were substantially different than the total FFA profiles. Myristic acid, for example, comprises 22% of the unbound versus 2.8% of the total. The most surprising difference is our finding of zero unbound -9-palmitoleic acid (POA), whereas the total POA was 7.2%. An unidentified plasma component appears to specifically prevent the release of POA. FFAus are the physiologically active FFAs, and plasma FFAu profiles may provide novel information about human health.
The membrane domains of mammalian adenylyl cyclases are lipid receptors.
Landau M, Elsabbagh S, Gross H, Fuchs A, Schultz A, Schultz J Elife. 2024; 13.
PMID: 39611663 PMC: 11606603. DOI: 10.7554/eLife.101483.
Mitochondrial bioenergetics, metabolism, and beyond in pancreatic β-cells and diabetes.
Rivera Nieves A, Wauford B, Fu A Front Mol Biosci. 2024; 11:1354199.
PMID: 38404962 PMC: 10884328. DOI: 10.3389/fmolb.2024.1354199.
Choe M, Titov D bioRxiv. 2024; .
PMID: 38234735 PMC: 10793441. DOI: 10.1101/2023.12.27.573435.
The Physiological and Pathological Role of Acyl-CoA Oxidation.
Szrok-Jurga S, Czumaj A, Turyn J, Hebanowska A, Swierczynski J, Sledzinski T Int J Mol Sci. 2023; 24(19).
PMID: 37834305 PMC: 10573383. DOI: 10.3390/ijms241914857.
Bergen J, Karasova M, Bileck A, Pignitter M, Marko D, Gerner C Arch Toxicol. 2023; 97(6):1659-1675.
PMID: 37117602 PMC: 10182945. DOI: 10.1007/s00204-023-03495-3.